DrShahidaDin
@shahidadin1
Gastroenterologist. IBD Researcher. Chair of the 🇬🇧 Society of Gastroenterology Inflammatory Bowel Disease (IBD) Committee @[email protected]
ID: 1092461044524556289
04-02-2019 16:33:04
3,3K Tweet
1,1K Takipçi
3,3K Takip Edilen
Several stakeholders have advocated for minimising placebo controlled RCTs. We analysed the harms [Adverse Events,[AEs]] associated with placebo in inflammatory bowel diseases (IBD) RCTs. Alexander Ford Beatriz Gros Jonathan Segal Jonny Blackwell Chris Black Luminal Gastroenterology Research Leeds
![Several stakeholders have advocated for minimising placebo controlled RCTs. We analysed the harms [Adverse Events,[AEs]] associated with placebo in inflammatory bowel diseases (IBD) RCTs. <a href="/alex_ford12399/">Alexander Ford</a> <a href="/Bealoquebea/">Beatriz Gros</a> <a href="/Jonathansegal85/">Jonathan Segal</a> <a href="/JonnyBlackwell/">Jonny Blackwell</a> <a href="/DrCJBlack/">Chris Black</a> <a href="/GastroRes_Leeds/">Luminal Gastroenterology Research Leeds</a>](https://pbs.twimg.com/media/GX34R7ZXcAAJcVS.jpg "DrShahidaDin (@shahidadin1) on Twitter photo Several stakeholders have advocated for minimising placebo controlled RCTs. We analysed the harms [Adverse Events,[AEs]] associated with placebo in inflammatory bowel diseases (IBD) RCTs. <a href=\"/alex_ford12399/\">Alexander Ford</a> <a href=\"/Bealoquebea/\">Beatriz Gros</a> <a href=\"/Jonathansegal85/\">Jonathan Segal</a> <a href=\"/JonnyBlackwell/\">Jonny Blackwell</a> <a href=\"/DrCJBlack/\">Chris Black</a> <a href=\"/GastroRes_Leeds/\">Luminal Gastroenterology Research Leeds</a>")